Showing 1 - 7 results of 7 for search 'Ying-Hao Shen', query time: 0.03s
Refine Results
-
1
Effectiveness and safety of lenvatinib plus anti‐programmed death‐1 antibodies in patients with hepatocellular carcinoma: A real‐world cohort study by Ming‐Hao Xu, Cheng Huang, Mei‐Ling Li, Xiao‐Dong Zhu, Chang‐Jun Tan, Jian Zhou, Jia Fan, Hui‐Chuan Sun, Ying‐Hao Shen
Published 2023-04-01
Article -
2
Criteria for identifying potentially resectable patients with initially oncologically unresectable hepatocellular carcinoma before treatment with lenvatinib plus an anti–PD–1 antib... by Bin Xu, Xiao-Dong Zhu, Ying-Hao Shen, Jin-Jin Zhu, Jie Liu, Mei-Ling Li, Pei-Wen Tang, Jian Zhou, Jia Fan, Hui-Chuan Sun, Cheng Huang
Published 2022-11-01
Article -
3
An mALBI-Child–Pugh-based nomogram for predicting post-hepatectomy liver failure grade B–C in patients with huge hepatocellular carcinoma: a multi-institutional study by Ming-Hao Xu, Bin Xu, Chen-Hao Zhou, Zhong Xue, Zhao-Shuo Chen, Wen-Xin Xu, Cheng Huang, Xiao-Dong Zhu, Jian Zhou, Jia Fan, Hui-Chuan Sun, Ying-Hao Shen
Published 2022-06-01
Article -
4
The Safety Profile of Hepatectomy Following Preoperative Systemic Therapy with Lenvatinib Plus Anti-PD-1 Antibodies Versus Hepatectomy Alone in Patients With Hepatocellular Carcino... by Ying-Hao Shen, MD, Cheng Huang, MD, Xiao-Dong Zhu, MD, Ming-Hao Xu, BS, Zhao-Shuo Chen, MS, Chang-Jun Tan, MD, Jian Zhou, MD, Jia Fan, MD, Hui-Chuan Sun, MD
Published 2022-06-01
Article -
5
Loss of 5-hydroxymethylcytosine induces chemotherapy resistance in hepatocellular carcinoma via the 5-hmC/PCAF/AKT axis by Xiao-Jun Guo, Xiao-Yong Huang, Xuan Yang, Jia-Cheng Lu, Chuan-Yuan Wei, Chao Gao, Yan-Zi Pei, Yi Chen, Qi-Man Sun, Jia-Bin Cai, Jian Zhou, Jia Fan, Ai-Wu Ke, Yujiang G. Shi, Ying-Hao Shen, Peng-Fei Zhang, Guo-Ming Shi, Guo-Huan Yang
Published 2023-02-01
Article -
6
Radiographic and α-fetoprotein response predict pathologic complete response to immunotherapy plus a TKI in hepatocellular carcinoma: a multicenter study by Cheng Huang, Xiao-Dong Zhu, Ying-Hao Shen, Bin Xu, Dong Wu, Yuan Ji, Ling-Li Chen, Tian-Qiang Song, Wei Zhang, Zhi-Ming Zeng, Hua-Sheng Huang, Kui Wang, Lan-Qing Huang, Yong-Jun Chen, Yu-Chen Yang, Le-Du Zhou, Guo Long, Hai-Tao Zhao, Yun-Chao Wang, Ning-Ling Ge, Yi Chen, Chang-Jun Tan, Jian Zhou, Jia Fan, Hui-Chuan Sun
Published 2023-05-01
Article -
7
Tumor radiomic features on pretreatment MRI to predict response to lenvatinib plus an anti–PD-1 antibody in advanced hepatocellular carcinoma: a multicenter study by Bin Xu, Sanyuan Dong, Xue-Li Bai, Tian-Qiang Song, Bo-Heng Zhang, Le-Du Zhou, Yong-Jun Chen, Zhi-Ming Zeng, Kui Wang, Hai-Tao Zhao, Na Lu, Wei Zhang, Xu-Bin Li, Su-Su Zheng, Guo Long, Yu-Chen Yang, Hua-Sheng Huang, Lan-Qing Huang, Yun-Chao Wang, Fei Liang, Xiao-Dong Zhu, Cheng Huang, Ying-Hao Shen, Jian Zhou, Meng-Su Zeng, Jia Fan, Sheng-Xiang Rao, Hui-Chuan Sun
Published 2022-11-01
Article